Helsinn adds first cancer therapeutic via MEI deal

Helsinn Healthcare S.A. (Lugano, Switzerland) is expanding its focus in cancer beyond supportive care through a licensing deal with MEI Pharma Inc. (NASDAQ:MEIP) for

Read the full 245 word article

How to gain access

Continue reading with a
two-week free trial.